Connor, Clark & Lunn Investment Management Ltd. Mirum Pharmaceuticals, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$26 Billion
Q2 2025

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 423,744 shares of MIRM stock, worth $22.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

423,744

Previous 356,276 18.94%

Holding current value

$22.6 Million

Previous $16.1 Million 34.36%

% of portfolio

0.08%

Previous 0.08%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$38.39 - $51.11 $2.59 Million - $3.45 Million	67,468 Added 18.94%	423,744 $21.6 Million
Q1 2025 May 12, 2025	BUY	$41.32 - $53.16 $7.41 Million - $9.53 Million	179,316 Added 101.33%	356,276 $16.1 Million
Q4 2024 Feb 10, 2025	BUY	$37.85 - $46.65 $4.15 Million - $5.11 Million	109,585 Added 162.65%	176,960 $7.32 Million
Q3 2024 Nov 08, 2024	BUY	$33.68 - $44.74 $724,995 - $963,073	21,526 Added 46.95%	67,375 $2.63 Million
Q2 2024 Aug 09, 2024	BUY	$23.57 - $34.85 $1.08 Million - $1.6 Million	45,849 New	45,849 $1.57 Million
Q4 2023 Feb 09, 2024	BUY	$27.14 - $34.93 $527,004 - $678,270	19,418 Added 17.02%	133,527 $3.94 Million
Q3 2023 Nov 13, 2023	BUY	$24.63 - $32.85 $1.88 Million - $2.51 Million	76,369 Added 202.36%	114,109 $3.61 Million
Q2 2023 Aug 10, 2023	BUY	$23.51 - $30.09 $887,267 - $1.14 Million	37,740 New	37,740 $976,000
Q3 2022 Nov 10, 2022	SELL	$19.98 - $29.44 $75,604 - $111,400	-3,784 Reduced 26.15%	10,689 $225,000
Q2 2022 Aug 05, 2022	SELL	$18.42 - $27.5 $157,196 - $234,685	-8,534 Reduced 37.09%	14,473 $282,000
Q1 2022 May 12, 2022	SELL	$15.5 - $23.93 $40,470 - $62,481	-2,611 Reduced 10.19%	23,007 $507,000
Q4 2021 Feb 10, 2022	BUY	$13.05 - $19.35 $334,314 - $495,708	25,618 New	25,618 $409,000

Others Institutions Holding MIRM

# of Institutions

230

Shares Held

55.9M

Call Options Held

27.4K

Put Options Held

105K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.96B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Mirum Pharmaceuticals, Inc. Transaction History